Journal
MOLECULAR THERAPY-NUCLEIC ACIDS
Volume 20, Issue -, Pages 606-620Publisher
CELL PRESS
DOI: 10.1016/j.omtn.2020.04.002
Keywords
-
Categories
Funding
- Hallym University Research Fund
- Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1A2B4012944]
Ask authors/readers for more resources
Inflammation is closely related with the progression of cancer and is an indispensable component that orchestrates the tumor microenvironment. Studies suggest that different mediator and cellular effectors, including cytokines (interleukins, tumor necrosis factor-alpha [TNF-alpha], transforming growth factor-beta [TGF-beta], and granulocyte macrophage colony-stimulating factor [GM-CSF]), chemokines, as well as some transcription factors (nuclear factor kappa B [NF-kappa B], signal transducer and activator of transcription 3 [STAT3], hypoxia-inducible factor-1 alpha [HIF1 alpha]), play a crucial role during cancer-related inflammation (CRI). MicroRNAs (miRNAs) are the key components of cellular physiology. They play notable roles during posttranscriptional gene regulation and, thus, might have a potential role in controlling the inflammatory cascade during cancer progression. Taking into consideration the role identified for miRNAs in relation to inflammatory cytokines, we have tried to review their participation in neoplastic progression. Additionally, the involvement of miRNAs with some important transcription factors (NF-kappa B, STAT3, HIF1 alpha) and proteins (cyclooxygenase-2 [COX-2], inducible nitric oxide synthase [iNOS]) closely associated with inflammation during cancer has also been discussed. A clear insight into the responsibility of miRNAs in cytokine signaling and inflammation related to CRI could project them as new therapeutic molecules, which could lead to improved treatment of CRI in the near future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available